Neuralstem adds board member
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Neuralstem Inc. appointed Xi Chen to its board, effective Dec. 20.
Chen succeeds Zhang Zhuo as the director appointee of Tianjin Kinnovata Pharmaceutical, where he serves as the assistant general manager of manufacture, equipment and administration.
